Beatrice Mintz

Beatrice Mintz, senior member, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia. Beatrice Mintz has turned her interest in the genetic control of pigment cell dvelopment toward basic research on the mechanisms underlying the progression and spread of melanoma. In 1993, she and her colleagues produced the first laboratory animal model of skin melanoma by genetically altering mice so that they become susceptible to this malignancy. The development and progression of tumors in t

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Beatrice Mintz, senior member, Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia.

Beatrice Mintz has turned her interest in the genetic control of pigment cell dvelopment toward basic research on the mechanisms underlying the progression and spread of melanoma. In 1993, she and her colleagues produced the first laboratory animal model of skin melanoma by genetically altering mice so that they become susceptible to this malignancy. The development and progression of tumors in thes mice is similar to those in human tumors. Through this research, Mintz aims to identify the means of preventing the advance and spread of the disease.

Mintz continues to strive to carry out creative and original scientific work. Her goal is to design experiments that have th epotential for raising new and unforeseen questions.

Mintz says:

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies